Chemistry:Nidufexor

From HandWiki
Revision as of 08:27, 2 May 2023 by Rjetedi (talk | contribs) (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Nidufexor
Nidufexor structure.png
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC27H22ClN3O4
Molar mass487.94 g·mol−1
3D model (JSmol)

Nidufexor (LMB-763) is a drug which acts as a partial agonist of the farnesoid X receptor (FXR). It has reached Phase II clinical trials for the treatment of diabetic nephropathy and nonalcoholic steatohepatitis.[1][2]

See also

References

  1. "Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis". Journal of Medicinal Chemistry 63 (8): 3868–3880. April 2020. doi:10.1021/acs.jmedchem.9b01621. PMID 31940200. 
  2. "Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)". Expert Opinion on Investigational Drugs 29 (6): 623–632. June 2020. doi:10.1080/13543784.2020.1763302. PMID 32552182.